Replies to post #20296 on NanoViricides Inc. (NNVC)

[TheDane]

Excellent!

[westeffer]

Isn't this the first trial info that was completed 6-9 months ago?

[cabel]

Nice news,...Thanks! Nice to see the web site updated as well!

I liked this part:

Dr. Boniuk will also report that the best nanoviricide drug candidate showed excellent long term results


Long Term Results look good!!!

[TheDane]

RE: Today's news...Is this comment by Dr. Seymour a friendly reminder to Big Pharma to step up the pace on whateverthefarktheyaredoing with their EKC-Cide testing?

"These results confirm that our EKC-Cide is likely the best available drug candidate in development against EKC," said Eugene Seymour, MD, MPH, CEO of the Company, adding, "We are now planning to evaluate its effect against herpes virus infection of the external eye."

Together, herpesviruses and adenoviruses are the principal causes of serious viral diseases of the external eye. At present, there is no satisfactory treatment for adenoviral keratitis/conjunctivitis. The potential domestic market for an effective drug against all viral infections of the external eye is variously estimated to be from $500M to billions of dollars.